Mooren, J. J. Et Al. 2014. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.. International journal of cancer , vol.134, no.9 , 2108-17.

Mooren, J. J., Gultekin, S. E., Straetmans, J. M. J. A. A., Haesevoets, A., Peutz-Kootstra, C. J., Huebbers, C. U., ... Dienes, H. P.(2014). P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.. International journal of cancer , vol.134, no.9, 2108-17.

Mooren, Jeroen Et Al. "P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.," International journal of cancer , vol.134, no.9, 2108-17, 2014

Mooren, Jeroen J. Et Al. "P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.." International journal of cancer , vol.134, no.9, pp.2108-17, 2014

Mooren, J. J. Et Al. (2014) . "P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.." International journal of cancer , vol.134, no.9, pp.2108-17.

@article{article, author={Jeroen J. Mooren Et Al. }, title={P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.}, journal={International journal of cancer}, year=2014, pages={2108-17} }